首页> 美国卫生研究院文献>other >A negative selection methodology using a microfluidic platform for the isolation and enumeration of circulating tumor cells
【2h】

A negative selection methodology using a microfluidic platform for the isolation and enumeration of circulating tumor cells

机译:使用微流体平台进行循环肿瘤细胞分离和计数的阴性选择方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Circulating tumor cells (CTCs) exist in the peripheral blood stream of metastatic cancer patients at rates of approximately 1 CTC per billion background cells. In order to capture and analyze this rare cell population, various techniques exist that range from antibody-based surface marker positive selection to methods that use physical properties of CTCs to negatively exclude background cells from a CTC population. However, methods to capture cells for functional downstream analyses are limited due to inaccessibility of the captured sample or labeling techniques that may be prohibitive to cell function. Here, we present a negative selection method that leverages a microfluidic cell concentrator (MCC) to allow collection and analysis of this rare cell population without needing cell adhesion or other labeling techniques to keep the cells within the chamber. Because the MCC is designed to allow collection and analysis of non-adherent cell populations, multiple staining steps can be applied in parallel to a given CTC population without losing any of the population. The ability of the MCC for patient sample processing of CTCs for enumeration was demonstrated with five patient samples, revealing an average of 0.31 CTCs per mL. The technique was compared to a previously published method – the ELISPOT – that showed similar CTC levels among the five patient samples tested. Because the MCC method does not use positive selection, the method can be applied across a variety of tumor types with no changes to the process.
机译:转移性癌症患者外周血中存在循环肿瘤细胞(CTC)的速率约为每十亿本底细胞1个CTC。为了捕获和分析这种稀有细胞群,存在各种技术,从基于抗体的表面标志物阳性选择到使用CTC物理特性将背景细胞从CTC群体中排除的方法。但是,由于无法获得捕获的样本或可能阻碍细胞功能的标记技术,捕获用于功能性下游分析的细胞的方法受到限制。在这里,我们介绍了一种负选择方法,该方法利用微流细胞浓缩器(MCC)来收集和分析这种稀有细胞群,而无需细胞粘附或其他标记技术来将细胞保持在腔室内。因为MCC旨在允许收集和分析非贴壁细胞群,所以可以对给定的CTC群并行进行多个染色步骤,而不会丢失任何群。五个患者样品证明了MCC对患者CTC进行样品处理的能力,揭示出平均每毫升0.31个CTC。将该技术与先前发布的方法ELISPOT进行了比较,该方法在所测试的五个患者样本中显示出相似的四氯化碳含量。由于MCC方法不使用阳性选择,因此该方法可以应用于多种肿瘤类型,而无需改变过程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号